(Q74029913)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

J Broderick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C Jackson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Pancioli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

B C Tilley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S C Fagan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Kothari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S R Levine

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J R Marler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P D Lyden

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E C Haley

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Brott

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J C Grotta

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

NINDS t-PA Stroke Study Group

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

736-744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

8 November 2019

cites work

1 reference

Alzheimer's disease, apolipoprotein E4, and gender.

21 January 2018

1 reference

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

21 January 2018

1 reference

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

Protection against Alzheimer's disease with apoE epsilon 2.

21 January 2018

1 reference

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

21 January 2018

1 reference

Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.

21 January 2018

1 reference

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

21 January 2018

1 reference

ApoE as a prognostic factor for post–traumatic coma

21 January 2018

1 reference

Association of apolipoprotein E polymorphism with outcome after head injury.

21 January 2018

1 reference

Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury

21 January 2018

1 reference

The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease

21 January 2018

1 reference

Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse

21 January 2018

1 reference

Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia

21 January 2018

1 reference

Hospital charges for stroke patients

21 January 2018

1 reference

Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy

21 January 2018

1 reference

High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage

21 January 2018

1 reference

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

21 January 2018

1 reference

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

21 January 2018

1 reference

Measurements of acute cerebral infarction: a clinical examination scale

21 January 2018

1 reference

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

Assessment of outcome after severe brain damage

21 January 2018

1 reference

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial

21 January 2018

1 reference

Analysis of data from multiclinic trials

21 January 2018

1 reference

Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study--dominance of the epsilon 2 allele?

21 January 2018

1 reference

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

21 January 2018

1 reference

Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line

21 January 2018

1 reference

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

21 January 2018

1 reference

A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins

21 January 2018

1 reference

Role of apolipoprotein E in lipoprotein metabolism

21 January 2018

1 reference

Apolipoprotein E polymorphism and atherosclerosis

21 January 2018

1 reference

Three-dimensional structure of the LDL receptor-binding domain of the human apolipoprotein E2 (Arg136-->Cys) variant

21 January 2018

1 reference

Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study

21 January 2018

1 reference

Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.

21 January 2018

1 reference

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

21 January 2018

1 reference

In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues

21 January 2018

1 reference

Amyloid beta peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase

21 January 2018

1 reference

Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e

21 January 2018

1 reference

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism

21 January 2018

1 reference

Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo

21 January 2018

1 reference

Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator

21 January 2018

1 reference

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

21 January 2018

1 reference

Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.1058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11409425%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference